AQUILA STUDY IN GERMANY - REAL WORLD ADHERENCE AND PERSISTENCE OF SECUKINUMAB TREATMENT IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS PATIENTS - AN INTERIM ANALYSIS

被引：8
|
作者：
Kiltz, Uta [1 ,2 ]
Peterlik, Daniel [3 ]
Winkelmann, Veronika [3 ]
Tony, Hans-Peter [4 ]
机构：
[1] Rheumazentrum Ruhrgebiet, Herne, Germany
[2] Ruhr Univ, Bochum, Germany
[3] Novartis Pharma GmbH, Clin Res Immunol Hepatol & Dermatol, Nurnberg, Germany
[4] Univ Klin, Med Klin 2, Rheumatol Immunol, Wurzburg, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY; DOUBLE-BLIND;
D O I：
10.1136/annrheumdis-2019-eular.435
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0705
引用
收藏
页码：1814 / 1815
页数：2
相关论文
共 50 条
  • [1] Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab
    Kiltz, Uta
    Sfikakis, Petros P.
    Gaffney, Karl
    Bounas, Andreas
    Gullick, Nicola
    Lespessailles, Eric
    Brandt-Juergens, Jan
    Rashkov, Rasho
    Schulz, Barbara
    Pournara, Effie
    Jagiello, Piotr
    RHEUMATOLOGY AND THERAPY, 2022, 9 (04) : 1129 - 1142
  • [2] The role of secukinumab in the treatment of psoriatic arthritis and ankylosing spondylitis
    Garcia-Montoya, Leticia
    Marzo-Ortega, Helena
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (09) : 169 - 180
  • [3] Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis
    Alegre-Sancho, Juan Jose
    Nunez-Monje, Victoria
    Campos-Fernandez, Cristina
    Balaguer-Trull, Isabel
    Robustillo-Villarino, Montserrat
    Aguilar-Zamora, Marta
    Garijo-Bufort, Marta
    Pedraz-Penalva, Teresa
    Pena-Gonzalez, Carolina
    de la Morena, Isabel
    Bedoya-Sanchis, Diego
    Yankova-Komsalova, Liliya
    Conesa-Mateos, Arantxa
    Martinez-Cristobal, Anna
    Navarro-Blasco, Francisco Javier
    Senabre-Gallego, Jose Miguel
    Sivera, Francisca
    FRONTIERS IN MEDICINE, 2023, 10
  • [4] The effect of secukinumab treatment on hematological parameters in ankylosing spondylitis and psoriatic arthritis
    Karatas, Ahmet
    Gercek, Aybuke Nisa
    Oz, Burak
    Gozel, Nevzat
    Sagir, Rabia Piskin
    Gur, Mustafa
    Koca, Suleyman Serdar
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2020, 7 (04) : 169 - 172
  • [5] Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis
    Elewski, Boni E.
    Baddley, John W.
    Deodhar, Atul A.
    Magrey, Marina
    Rich, Phoebe A.
    Soriano, Enrique R.
    Soung, Jennifer
    Bao, Weibin
    Keininger, Dorothy
    Marfo, Kwaku
    Patekar, Manmath
    Sharma, Abhishek
    Shete, Abhijit
    Lebwohl, Mark Gabriel
    JAMA DERMATOLOGY, 2021, 157 (01) : 43 - 51
  • [6] Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis
    Deodhar, Atul
    Gladman, Dafna D.
    McInnes, Iain B.
    Spindeldreher, Sebastian
    Martin, Ruvie
    Pricop, Luminita
    Porter, Brian
    Safi, Jorge, Jr.
    Shete, Abhijit
    Bruin, Gerard
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (04) : 539 - 547
  • [7] Secukinumab Use in Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis in Real-World Setting in Europe: Baseline Data from SERENA Study
    Kiltz, Uta
    Sfikakis, Petros P.
    Gaffney, Karl
    Sator, Paul-Gunther
    von Kiedrowski, Ralph
    Bounas, Andreas
    Gullick, Nicola
    Conrad, Curdin
    Rigopoulos, Dimitris
    Lespessailles, Eric
    Romanelli, Marco
    Ghislain, Pierre-Dominique
    Brandt-Juergens, Jan
    Rashkov, Rasho
    Aassi, Maher
    Orsenigo, Roberto
    Perella, Chiara
    Pournara, Effie
    Gathmann, Sven
    Jagiello, Piotr
    Veit, Justyna
    Augustin, Matthias
    ADVANCES IN THERAPY, 2020, 37 (06) : 2865 - 2883
  • [8] Real-Life Data of Secukinumab in Patients with Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis: Patient Baseline Characteristics Data from the PROMPT Study
    Rattanakaemakorn, Ploysyne
    Chevaisrakul, Parawee
    Wongpraparut, Chanisada
    Chiowchanwisawakit, Praveena
    Tovanabutra, Napatra
    Tantiwong, Pimchanok
    Amornpinyo, Warayuwadee
    Chakkavittumrong, Panlop
    Hanvivadhanakul, Punchong
    Chaiamnuay, Sumapa
    Laodheerasiri, Supapat
    Pattamadilok, Bensachee
    Choonhakarn, Charoen
    Mahakkanukrauh, Ajanee
    Aiewruengsurat, Duangkamol
    Sangmala, Siripan
    Pretikul, Nisa
    Sumethkul, Kittiwan
    Satpanich, Panchalee
    Boonsiri, Metavee
    Sangob, Naruemon
    Asawanonda, Pravit
    DERMATOLOGY AND THERAPY, 2024, 14 (12) : 3229 - 3241
  • [9] Real world effectiveness and satisfaction with secukinumab in the treatment of patients with psoriatic arthritis: a population survey in five European countries
    Conaghan, Philip G.
    Keininger, Dorothy L.
    Holdsworth, Elizabeth A.
    Booth, Nicola
    Modi, Niraj N.
    Tian, Haijun
    Kiltz, Uta
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (10) : 1845 - 1853
  • [10] Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis
    Paramarta, Jacqueline E.
    De Rycke, Leen
    Heijda, Tanja F.
    Ambarus, Carmen A.
    Vos, Koen
    Dinant, Huib J.
    Tak, Paul P.
    Baeten, Dominique L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (11) : 1793 - 1799
12345